2013•Leukemia ResearchRequires access

10 years of experience with thalidomide in multiple myeloma patients: Report of the Czech Myeloma Group

Jiří Minařík, Viera Sandecká, Vladimír Maisnar, Evzen Gregora, Ivan Špıčka, David Starostka, Hana Plonková, Jiří Jarkovský, Lenka Walterová, Marek Wróbel, D. Adamová, Tomáš Pika, Hana Melicharova, Luděk Pour, Jakub Radocha, Petr Pavlíček, Jan Štraub, Jaromír Gumulec, Jaroslav Bačovský, Zdeněk Adam, Vlastimil Ščudla, Roman Hájek

Open publisher page 4 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Thalidomide, Multiple myeloma, Medicine, Adverse effect, Autologous stem-cell transplantation, Dexamethasone, Internal medicine, Oncology

Related papers

Back to paper searchBrowse research topicsOriginal source
10 years of experience with thalidomide in multiple myeloma patients: Report of the Czech Myeloma Group — Research Paper | ScholarLens